Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
WGS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
-1.65
vs -0.25
Q3.23
N/A
-0.82
vs -0.20
Q4.23
N/A
-0.59
vs -0.25
Q1.24
N/A
-0.33
vs -2.82
Q2.24
N/A
-0.11
vs -1.65
Q3.24
+105%
0.04
vs -0.82
Q4.24
+219%
0.7
vs -0.59
Q1.25
+185%
0.28
vs -0.33
Q2.25
+208%
0.12
vs -0.11
Q3.25
+547%
0.26
vs 0.04
Sales Growth
YoY
Current
Estimates
Q2.23
+35%
48.7M vs 36.2M
Q3.23
-36%
53.3M vs 83.2M
Q4.23
-6%
57.4M vs 61.4M
Q1.24
+45%
62.4M vs 43.1M
Q2.24
+45%
70.5M vs 48.7M
Q3.24
+44%
76.9M vs 53.3M
Q4.24
+67%
95.6M vs 57.4M
Q1.25
+40%
87.1M vs 62.4M
Q2.25
+21%
85.6M vs 70.5M
Q3.25
+22%
93.4M vs 76.9M
Return on Equity
QoQ
Q2.23
-16%
-0.16
vs -0.19
Q3.23
-17%
-0.17
vs -0.16
Q4.23
-11%
-0.11
vs -0.17
Q1.24
-10%
-0.10
vs -0.11
Q2.24
-15%
-0.15
vs -0.10
Q3.24
-4%
-0.04
vs -0.15
Q4.24
+2%
0.02
vs -0.04
Q1.25
-3%
-0.03
vs 0.02
Institutionnal Ownership
QoQ
Q2.23
62
62
vs 2
3000%
Q3.23
58
58
vs 62
-6%
Q4.23
50
50
vs 58
-14%
Q1.24
61
61
vs 50
22%
Q2.24
92
92
vs 61
51%
Q3.24
145
145
vs 92
58%
Q4.24
211
211
vs 145
46%
Q1.25
243
243
vs 211
15%
seekingalpha.com
2 hours ago
Forecast
408%2026-Revenue
989%2026-EPS
-7190%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
0.00(-100.00%)
Number of analyst
0
Last analyst upgrade/downgrade
Guggenheim
initialisePrevious: Not converted
2025-05-15
Now: Buy
Wells Fargo
initialisePrevious: Not converted
2024-08-27
Now: Equal-Weight
Craig-Hallum
initialisePrevious: Not converted
2024-07-10
Now: Buy
Quote Panel
Key Metrics
Relative Strength
WGS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
NASDAQ
-2.55Â ( -3.17%)
After-hours 78.38$0.51 (0.65%)
Relative Strenght
90
Volume Buzz
-43%
Earning Acce
No
Dist 52w H.
34%